RPO LLC’s Senti Biosciences Holdings SNTI Stock Holding History

RPO LLC’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,871	Closed	-$480K	–	169
2022 Q1	$480K	Buy	+4,871	New	+$481K	0.16%	101

Other funds holding SNTI

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Financial Management Network Mission Viejo, California $653M AUM 17.76% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return

RPO LLC's SNTI Position: Q2 2022 in Review

RPO LLC sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 4,871 shares — an estimated $480K sold.

RPO LLC first reported a position in SNTI in Q1 2022 and held it in 1 quarter. The position peaked at $480K in Q1 2022. 22 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

RPO LLC reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
RPO LLC sold 4,871 Senti Biosciences Holdings shares in Q2 2022, an estimated $480K.
RPO LLC first reported a position in Senti Biosciences Holdings in Q1 2022 and held it in 1 quarter.
RPO LLC's Senti Biosciences Holdings position peaked at $480K in Q1 2022.
22 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on RPO LLC's 13F filing for Q2 2022, filed 11 Aug 2022.